| 0.6524 0.045 (7.37%) | 03-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.84  |
1-year : | 0.96 |
| Resists | First : | 0.71 |
Second : | 0.82 |
| Pivot price | 0.6 |
|||
| Supports | First : | 0.54 | Second : | 0.44 |
| MAs | MA(5) : | 0.59 |
MA(20) : | 0.61 |
| MA(100) : | 0.74 |
MA(250) : | 0.96 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 36.5 |
D(3) : | 24.7 |
| RSI | RSI(14): 45.2 |
|||
| 52-week | High : | 1.84 | Low : | 0.54 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ZTEK ] has closed below upper band by 39.4%. Bollinger Bands are 32.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.67 - 0.67 | 0.67 - 0.67 |
| Low: | 0.56 - 0.57 | 0.57 - 0.57 |
| Close: | 0.61 - 0.62 | 0.62 - 0.62 |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Mon, 02 Mar 2026
Zentek Ltd. - common stock (NQ: ZTEK - The Chronicle-Journal
Mon, 02 Mar 2026
ZTEK SEC Filings - Zentek Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Fri, 27 Feb 2026
ZTEK Should I Buy - Intellectia AI
Thu, 26 Feb 2026
Zentek (NASDAQ: ZTEK) plans new PEA and PFS path for Albany Graphite - Stock Titan
Wed, 25 Feb 2026
Nasdaq grants Zentek (NASDAQ: ZTEK) 180-day minimum bid-price extension - Stock Titan
Wed, 25 Feb 2026
Nasdaq gives Zentek 6 more months to lift share price above $1 - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 107 (M) |
| Held by Insiders | 1.027e+008 (%) |
| Held by Institutions | 5.5 (%) |
| Shares Short | 38 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.37e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 155.2 % |
| Return on Equity (ttm) | -30.1 % |
| Qtrly Rev. Growth | 942880 % |
| Gross Profit (p.s.) | 170 |
| Sales Per Share | -131.73 |
| EBITDA (p.s.) | 1.10679e+006 |
| Qtrly Earnings Growth | -0.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 3.32 |
| Dividend | 0 |
| Forward Dividend | 40800 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|